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Complex formation processes of [Ru(η6-p-cymene)(H2O)3]
+ and [Rh(η5-C5Me5)(H2O)3]
+ organometallic cations with  
8-hydroxyquinoline (HQ) ligands were studied in aqueous solution by the combined use of 1H NMR spectroscopy, UV-
visible spectrophotometry and pH-potentiometry. Solution stability, chloride ion affinity and lipophilicity of the complexes 
were characterized together with the in vitro cytotoxicity against a pair of cancer cell lines, responsive and resistant to 
classic chemotherapy. The solid phase structure of the [Rh(η5-C5Me5)(8-quinolinolato)(Cl)] complex was characterized by 
single-crystal X-ray diffraction analysis. In addition to the unsubstituted HQ its 7-(1-piperidinylmethyl) (PHQ) and 5-
sulfonate (HQS) derivatives were involved. PHQ has a significant preference for targeting multidrug resistant cancer cell 
lines, while HQS served as a water soluble model compound. The equilibrium studies revealed the formation of mono 
[M(L)(H2O)] complexes with prominently high solution stability, which predominate at physiological pH even in the 
micromolar concentration range, and formation of mixed hydroxido [M(L)(OH)] complexes was characterized by relatively 
high pKa values (8.5–10.3). In comparison to the Rh(η
5-C5Me5) species the complexation process with Ru(η
6-p-cymene) is 
much slower, and both the pKa values and the H2O/Cl
− co-ligand exchange constants are lower by 1-1.5 orders of 
magnitude. The stability order obtained for these organometallic complexes is as follows: HQS > HQ > PHQ. Cytotoxicity of 
the ligands and their Ru(η6-p-cymene) and Rh(η5-C5Me5) complexes was investigated against MES-SA (human uterine 
sarcoma) cell line and its multidrug resistant counterpart (MES-SA/Dx5). HQ and its complexes show similar cytotoxicity in 
both cell lines. In contrast, PHQ and its Rh(η5-C5Me5) complex are more potent against MES-SA/Dx5 cells, while this 
selectivity could not be observed for the Ru(η6-p-cymene) complex. 
 
Introduction 
Resistance and the serious side effects associated with the use of 
anticancer platinum drugs used in chemotherapy are still driving for 
the design and development of novel metal-based compounds that 
combine good efficacy, selectivity and low systemic toxicity due to 
their different mode of action and pharmacokinetics. Ruthenium 
complexes have been the subject of extensive drug discovery 
efforts, yielding e.g. the sodium trans-[tetrachloridobis(1H-
indazole)ruthenate(III)] (NKP-1339, IT-139) and imidazolium 
trans-[tetrachlorido(DMSO)(imidazole)ruthenate(III)] (NAMI-A) as 
the most promising compounds reaching clinical trials.
1-4
 These 
ruthenium(III) complexes are considered as prodrugs activated by 
reduction. Organoruthenium(II) compounds have gained increasing 
attention recently and numerous [Ru(
6
-arene)(X)(Y)(Z)] complexes 
were found to be active as antitumor compounds.
5
 One of the most 
well-known ruthenium(II) arene complexes [Ru(η
6
-p-
cymene)Cl2(PTA)] (PTA = 1,3,5-triaza-7-phosphatricyclo-
[3.3.1.1]decane) shows anti-metastatic properties and is ready for 
translation to clinical evaluation.
6
 However, in most of the half-
sandwich organoruthenium(II) compounds a bidentate ligand with 
an (O,O), (O,S), (O,N), (N,N) or (N,S) binding mode is coordinated 
and a chloride ion acts as the leaving group.
7-11
 The replacement of 
the chlorido ligand by a water molecule facilitates the reaction with 
biological macromolecules such as proteins or DNA,
12
 while the 
chelating ligand allows modifications of the chemical properties, 
ligand exchange rate, lipophilicity, 3D shape and ultimately 
influences the pharmacological effect. Rhodium(III) is isoelectric 
with ruthenium(II) and the coordination of e.g. the anionic 
pentamethylcyclopentadienyl (C5Me5
–
) ligand results in faster ligand 
exchange kinetics.
13
 Promising in vitro antitumor activity has been 
reported for Rh(
5
-C5Me5) complexes of (N,N) donating polypyridyl 
ARTICLE Journal Name 
2 | J. Name., 2017, 00, 1-3 This journal is © The Royal Society of Chemistry 20xx 
Please do not adjust margins 
Please do not adjust margins 
ligands by Sheldrick and his co-workers.
14,15
 Recently we reported 
Rh(
5
-C5Me5) complexes formed with (O,O) donor 
hydroxypyr(id)ones (maltol, deferiprone) showing moderate 
cytotoxicity on various cancer cell lines,
16,17
 while the complexes of 
(N,O) donor picolinates exhibited only poor anticancer activity.
17,18
 
Both Rh(
5
-C5Me5) and Ru(η
6
-p-cymene) half-sandwich complexes 
of the (N,O) donor 8-hydroxyquinoline (HQ, Chart 1) are reported to 
possess antitumor activity with IC50 values in the low micromolar 
concentration range.
19-21
 These complexes were characterized by 
standard analytical methods 
19-24
 and in the case of the [Ru(η
6
-p-
cymene)(L)(Cl)] and [Ru(η
6
-p-cymene)(L)(H2O)]
+
 (L: 8-quinolinolato) 
in the solid state by single-crystal X-ray diffraction analysis.
23,24
 
Notably, in a set of Ru(η
6
-p-cymene) half-sandwich complexes with 
8-HQ derivatives it was found that the introduction of halogens in 
positions R5 and R7 of the scaffold increased both anticancer 
cytotoxicity and intracellular accumulation, suggesting that these 
two moieties might be relevant for the fine tuning of the biological 
activity of these complexes.
21
 Excellent cytotoxic effect in tumor cell 
lines was found for water soluble mixed-ligand [Ru(η
6
-p-cymene)(8-
quinolinolato)(H-azole heterocycle)]
+
 complexes.
20
 In addition, 
Ru(η
6
-p-cymene) complexes of various HQ derivatives have been 
found to catalyze the hydrogenation of CO2 to formate in aqueous 
solution and the catalytic activity showed strong pH-dependence.
24
 
Although these 8-quinolinolato complexes have been extensively 
studied, their solution speciation and stability constants are not 
available in the literature. For the better understanding of the 
pharmacokinetic profile and mechanisms of action of these metal 
complexes in addition to their pH-dependent catalytic activity, the 
knowledge of the speciation and the most plausible chemical forms 
in aqueous solution, especially at physiological pH, is a mandatory 
prerequisite. Therefore, one of the aims of the present study was to 
characterize the solution speciation of Rh(
5
-C5Me5) and Ru(
6
-p-
cymene) complexes of HQ in aqueous solution involving studies on 
their chloride ion affinity and lipophilicity. 
HQ is a privileged structure, which appears frequently in drugs, 
natural compounds, or bioactive molecules and is used as a ligand 
in the orally active tris(8-quinolinolato)gallium(III) complex (KP46), 
currently undergoing clinical trials.
25,26
 The HQ derived Mannich 
base 7-(1-piperidinylmethyl)-HQ (NSC57969, PHQ, Chart 1) has 
recently been identified to overcome multidrug resistance (MDR) in 
cancer, a phenomenon conferring resistance to a wide range of 
structurally and mechanistically unrelated anticancer agents.
27-29
 
Several related derivatives have been identified to show 
paradoxically enhanced cytotoxicity against MDR cell lines 
overexpressing P-glycoprotein (P-gp), a transport protein mediating 
resistance by effluxing chemotherapeutic agents from cancer cells, 
thereby keeping their intracellular concentrations below a cell-
killing threshold.
27-30 
 
 
 
Chart 1. Chemical structures of the ligands: 8-hydroxyquinoline (HQ), 8-
hydroxyquinoline-5-sulfonate (HQS) and 7-(1-piperidinylmethyl)-8-
hydroxyquinoline (PHQ). 
 
In this work, our additional aim was to investigate the complex 
formation processes of PHQ in comparison to the HQ scaffold and 
the R5 substituted HQS with [Ru(η
6
-p-cymene)(H2O)3]
+
 and [Rh(
5
-
C5Me5)(H2O)3]
+
 cations and to reveal their cytotoxic effectiveness. 
Results and discussion 
Proton dissociation processes of the ligands (HQ, HQS, PHQ) and 
hydrolysis of the organometallic cations 
HQ and 8-hydroxyquinoline-5-sulfonate (HQS) (Chart 1) are well-
known compounds and their proton dissociation processes have 
already been described in the literature.
31-34
 Due to the insufficient 
water solubility of HQ, HQS was involved in the studies and 
considered as a model compound possessing the same coordination 
mode as HQ. Notably, proton dissociation constants of HQ and HQS 
(Table 1) were determined herein by UV-visible (UV-vis) 
spectrophotometry and 
1
H NMR spectroscopy (pH-dependent NMR 
spectra for HQS are shown in Figure S1) at 1 mM concentration. 
Data obtained by the different methods in the chloride-free 
condition are in good agreement with each other and with the 
previously published data obtained by pH-potentiometry.
31
 pK1 is 
attributed to the deprotonation of the quinolinium (NH
+
) group and 
pK2 belongs to the hydroxyl moiety. The sulfonic acid group of HQS 
is deprotonated in the whole pH range studied due to its strong 
acidic character. Notably, the deconvolution of the UV-vis spectra 
recorded at various pH values using ten times more diluted 
conditions (cL ~ 0.1 mM) gave lower pK1, and somewhat higher pK2 
constants for both ligands (see the dissimilar positions of the 
inflection points in Figure S2 for the pH-dependent absorbance 
values obtained for HQS at the two kinds of concentrations).
 
Table 1 Proton dissociation constants (pKa) of the studied ligands HQ, HQS and PHQ determined by various methods {T = 25 C; I = 0.2 M (KNO3)}.
a 
       HQ        HQS     PHQ 
method cL pK1
 pK2
 pK1
 pK2
 pK1
 pK2
 
pH-metry 1 mM 4.99b 9.51b 3.90b 8.37b ‒ ‒ 
1H NMR 1 mM ‒ ‒ 3.92(1) 8.38(1) ‒ ‒ 
UV-Vis 1 mM 5.03(1) 9.66(1) 3.83(1) 8.39(1) ‒ ‒ 
UV-Vis ~0.1 mM 4.78(1) 9.74(1) 3.63(1) 8.48(1) 2.80(1) 6.93(1) 
a Uncertainties (SD) of the last digits are shown in parentheses. b Data taken from ref. 31. 
N
OH
N
N
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N
OH
SO3
-
HQ HQS PHQ
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The concentration dependent pKa values of these compounds might 
be the result of a slightly altered ratio of the  and  (or cis/trans) 
HL forms
35
 under the two kinds of condition. 
The deprotonation of the piperidine derivative PHQ has also two 
pKa values attributed to the same moieties as in the case of HQ, but 
PHQ has 3 protonation sites, and the methylpiperidinium nitrogen 
is most probably protonated in pH range 2‒11.5. The corresponding 
pKa values of PHQ and HQS are significantly lower than those of HQ 
due to the electron withdrawing effect of the protonated 
piperidinium moiety and the sulfonate substituent, respectively. 
The hydrolytic behavior of the aquated organometallic cations 
[Ru(
6
-p-cymene)(H2O)3]
2+ 
and [Rh(
5
-C5Me5)(H2O)3]
2+ 
has been 
studied previously.
16,36-38
 The structure of the major hydrolysis 
products of [Rh(
5
-C5Me5)(H2O)3]
2+ 
the dimeric [(Rh(
5
-C5Me5))2(μ-
OH)3]
+ 
species was characterized by single-crystal X-ray analysis
39
 
and the similar structure is assumed for the [(Ru(
6
-p-cymene))2(μ-
OH)3]
+
 complex based on 
1
H NMR studies.
40
 Overall stability 
constants were reported for the μ-hydroxido-bridged dinuclear 
ruthenium(II) species ([(Ru(
6
-p-cymene)2(μ-OH)3]
+
) by Buglyó et 
al.,
36
 and for the rhodium(III) species [(Rh(
5
-C5Me5))2(μ-OH)3]
+
, 
[(Rh(
5
-C5Me5))2(μ-OH)2]
2+
) by some of us,
16
 and were used in this 
work for the calculations. 
 
Complex formation equilibria of [Rh(
5
-C5Me5)(H2O)3]
2+
 with HQ, 
HQS and PHQ 
The complex formation equilibrium processes in the case of the 
[Rh(
5
-C5Me5)(H2O)3]
2+ 
‒ HQS system was found to be fast and the 
species involved in the equilibria have good water solubility. These 
features allowed us the combined use of pH-potentiometry, 
1
H 
NMR spectroscopy and UV-vis spectrophotometry in a chloride-free 
medium. Notably, HQS was used as a model compound for HQ and 
PHQ, the biologically more interesting compounds, as its good 
solubility in water allowed us the simultaneous use of the various 
techniques. The complexation between [Rh(
5
-C5Me5)(H2O)3]
2+ 
and 
HQS follows a fairly simple scheme (Chart S1.), since a mono-ligand 
[Rh(
5
-C5Me5)(L)(H2O)] (=[ML]) complex is formed with this 
bidentate ligand, and a mixed hydroxido [ML(OH)]
‒
 species appears 
by the deprotonation of the coordinated water molecule in the 
basic pH range, similarly to the behavior of numerous half-sandwich 
organorhodium complexes studied previously.
16-18,41
 The pH-
potentiometric titration data reveal almost complete complex 
formation already at the starting pH (~2), therefore the stability 
constant of this [ML] type complex (Table 2) was determined by 
deconvolution of UV-Vis spectra measured between pH 0.7 and 3.0 
(Figure 1.a). (M always denotes the metal ion moiety: [Rh(
5
- 
C5Me5)(H2O)3]
2+ 
or [Ru(
6
-p-cymene)(H2O)3]
2+
). 
These spectra were recorded for individual samples, in which the 
KNO3 was partially or completely replaced by HNO3 keeping the 
ionic strength constant and the actual pH values were calculated 
based on the strong acid content. The recorded UV-Vis spectra 
were the same at pH between 2.9 and ~8, while significant changes 
of the charge-transfer band are seen at pH > 8.5, and λmax is shifted 
from 376 nm up to 384 nm. In addition, a well-isolated isobestic 
point is observed at 432 nm showing a clean transformation of the 
[ML] complex to another species, most probably [ML(OH)]
‒
. The 
appearance of the isobestic point suggests that the metal complex 
does not decompose under this condition, merely it is 
deprotonated. 
 
Table 2 Stability constants (logK [ML]), pKa [ML] values of the Rh(
5-C5Me5) 
and Ru(6-p-cymene) complexes formed with HQS, HQ and PHQ in chloride-
free aqueous solutions determined by various methods; H2O/Cl
‒ exchange 
constants (logK’) for the [Rh(5-C5Me5)(L)(H2O)] and [Rh(
6-p-
cymene)(L)(H2O)] complexes {T = 25 C; I = 0.2 M (KNO3)}.
a 
 method constants HQS HQ PHQ 
R
h
(
5 -
C
5M
e
5)
 UV-Vis logK [ML] 14.52(2)
b 15.02(3) 12.38(6)b 
UV-Vis pKa [ML] 10.10(1) 10.27(5) 10.08(2) 
1H NMR  pKa [ML] 10.12(1) ‒ ‒ 
pH-metry pKa [ML] 9.90(7) ‒ ‒ 
UV-Vis logK’ (H2O/Cl
‒)c 1.54(1) 1.81(1) 1.61(2) 
R
u
(
6
-p
-c
ym
e
n
e
) UV-Vis logK [ML] ‒ 16.53(2)b 13.31(4)b 
UV-Vis pKa [ML] 8.46(2) 9.19(4) 9.37(6) 
1H NMR  logK [ML] ≥16d ‒ ‒ 
1H NMR  pKa [ML] 8.52(3) ‒  ‒ 
UV-Vis logK’ (H2O/Cl
‒)c 0.64(4) 0.89(2) 1.19(2) 
a Uncertainties (SD) of the last digits are shown in parentheses. M denotes Rh(5-
C5Me5) and Ru(
6-p-cymene), respectively and aqua ligands and the charges of the 
complexes are not shown for clarity. Hydrolysis products of the organometallic 
cations: log [(Rh(5-C5Me5))2H‒2(H2O)2]
2+ = ‒8.53, log [(Rh(5-C5Me5))2H‒3]
+ = 
-14.26 and log [(Ru(6-p-cymene))2H‒3]
+ = ‒9.36 at I = 0.20 M (KNO3) taken from 
refs. 16,37. b Determined by UV-Vis spectrophotometry at pH 0.7‒3.0. c For the 
[Rh(5-C5Me5)(L)(H2O)]
+ + Cl− ⇌ [Rh(5-C5Me5)(L)Cl] + H2O and [Ru(
6-p-
cymene)(L)(H2O)]
+ + Cl− ⇌ [Ru(6-p-cymene)(L)Cl] + H2O respectively, equilibria 
determined at various total chloride ion concentrations by UV-Vis. d Estimated from 
the 1H NMR peak integrals of the ligand protons in the bound and unbound forms at 
pH 0.7. 
 
 
1
H NMR spectra recorded for the [Rh(
5
-C5Me5)(H2O)3]
2+ 
‒ HQS 
system at 1:1 metal-to-ligand ratio at various pH values (Figure 2) 
undoubtedly reveal that neither free metal ion nor ligand are 
present at pH > 2.9, which means that the complex does not suffer 
from decomposition due to its outstanding high stability at 1 mM 
concentration. An upfield shift of all peaks belonging to the [ML] 
complex is observed in the basic pH range due to the fast exchange 
process between the aquated and the mixed hydroxido species. 
Therefore, pKa of the aqua complex could be determined on the 
basis of the pH- dependent chemical shift (δ) values, which is in an 
excellent agreement with the data obtained spectro-
photometrically, while a somewhat lower pKa [ML] could be 
calculated based on the pH-potentiometric titrations (Table 2). 
As HQ, PHQ and their metal complexes have much lower solubility 
in water compared to that of HQS, their complexation processes 
could only be studied by UV-vis spectrophotometry using much 
lower concentrations (cL ~ 50‒160 M). The behavior of these 
ligands was found to be quite similar to that of the reference 
compound HQS, however the complex formation with HQ stars at 
higher pH due to the higher pKa values, thus stronger basicity of this 
ligand (Figure 3). The equilibrium constants providing the best fits 
to the experimental data are listed in Table 2. 
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Fig. 1. UV–Vis spectra recorded for the [Rh(5-C5Me5)(H2O)3]
2+ – HQS (1:1) 
system at pH 0.7 – 1.9 (a) and pH 2.0 – 11.7 (b). Dashed spectrum shows the 
sum of those of HQS and [Rh(5-C5Me5)(H2O)3]
2+.{cL = cRh = 160 M; T = 25 ˚C; 
I = 0.20 M (KNO3)}.  
 
 
Fig. 2. 1H NMR spectra recorded for the [Rh(5-C5Me5)(H2O)3]
2+ – HQS (1:1) 
system at the indicated pH values (peak assignation: CH(2) (■), CH(4) (●), 
C5Me5 (▼,∇), empty symbol = unbound organometallic cation). {cHQS = 
1 mM; T = 25 ˚C; I = 0.20 M (KNO3); 10% D2O}. 
 
 
Concentration distribution curves for the [Rh(
5
-C5Me5)(H2O)3]
2+ 
‒ 
HQ / PHQ systems were computed on the basis of the stability 
constants (Figure 4), which represent the predominant formation of 
the [Rh(
5
-C5Me5)(L)(H2O)] complexes in the pH range from 4 to 8 in 
both cases at the biologically more relevant 50 M concentration. 
 
 
Fig. 3. UV–Vis spectra recorded for the [Rh(5-C5Me5)(H2O)3]
2+ – HQ (1:1) 
system at pH 2.0– 11.5. Inset shows the absorbance values at 400 nm 
plotted against the pH. {cL = cRh = 150 M; T = 25 ˚C; I = 0.20 M (KNO3)}. 
 
 
Fig. 4. Concentration distribution curves for the [Rh(5-C5Me5)(H2O)3]
2+ – HQ 
(black lines) and [Rh(5-C5Me5)(H2O)3]
2+ – PHQ (grey lines) (1:1) systems 
calculated on the basis of the stability constants determined.  
{cRh = cL = 50 M; T = 25 ˚C; I = 0.20 M (KNO3); n = 1 (HQ), 2 (PHQ)}.  
 
 
Notably, the pKa [ML] values of these Rh(
5
-C5Me5) complexes are 
rather high (~10) and consequently the formation of mixed 
hydroxido species at pH 7.4 is negligible in the absence of chloride 
ions. The presence of the chloride ions generally results in even 
higher pKa [ML] values,
16,17,41
 therefore the deprotonation of the 
[Rh(
5
-C5Me5)(L)(H2O)] complexes of 8-hydroxyquinolines is not 
likely under physiological condition. 
In the studied Rh(
5
-C5Me5) complexes the bidentate 8-
hydroxyquinoline ligands coordinate most probably via (N,O
‒
) donor 
set, which was confirmed by X-ray crystallography in the case of HQ 
(see next section). 
 
Crystallographic structure determination of complex [Rh(
5
-
C5Me5)(8-quinolinolato)(Cl)](1) 
Single crystals of [Rh(
5
-C5Me5)(8-quinolinolato)(Cl)] (1) were 
obtained by the slow diffusion method from an ethanol/water 
mixture at neutral pH and at room temperature. The crystal 
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structure has been determined by single crystal X-ray diffraction, 
crystal data and structure refinement parameters are seen in Table 
S1. The ORTEP representation of the complex is depicted in Figure 
5a, while the packing arrangement is shown in Figure S3. Selected 
bond distances and angles are collected and given in comparison to 
the analogous iridium(III) complex
22
 in Table 3. The complex [Rh(
5
-
C5Me5)(8-quinolinolato)(Cl)] crystallized in the monoclinic crystal 
system, in space group Cc with three water molecules in the 
asymmetric unit. 
 
 
Fig. 5. Molecular structure of the metal complex [Rh(5-C5Me5)(8-
quinolinolato)(Cl)] (1) with the indication of rings (A-C). Displacement 
parameters are drawn at 50% probability level and solvent molecules and 
hydrogens are omitted for clarity (a). Comparison of the molecular structure 
of complex 1 (colored by element) with [Ir(5-C5Me5)(8-quinolinolato)(Cl)] 
(CSD ref. code VUMQAW) (rose)22 (b). 
 
As it is expected, the rhodium(III) center exhibits a 
pseudooctahedral (“piano-stool”) geometry, and the C5Me5 moiety 
occupies facially three coordination sites, while the deprotonated 
ligand is bidentate via its (N,O) donors and the coordination sphere 
is completed with a chlorido ligand. The binding of the different 
donor groups resulted in a pseudo chiral center for Rh, 
notwithstanding the complex crystallized in a racemic form. The 
measured Rh–N and Rh–Cl bond lengths were found to be very 
similar to the reported values for this complex based on DFT 
calculations (Rh–N: 2.115 Å, Rh–Cl: 2.416(2) Å).
19
 On the other hand 
the measured Rh–O bond length is somewhat longer, while the Rh–
ring centroid distance is significantly shorter than the calculated 
values (Rh–O: 2.065 Å, Rh–ring centroid: 1.887 Å).
19
 The molecular 
structure of the complex was compared directly with that of [Ir(
5
-
C5Me5)(quinolin-8-olate)(Cl)] (Figure 5b.), which crystallized without 
solvate inclusion in the orthorhombic Pna21 space group (unit cell 
dimensions are a = 15.285(3), b = 8.335(2), c = 13.626(3) Å).
22
  
The metal ion–C5Me5 ring centroid distance is very similar for the 
two complexes (1.768(3) Å in rhodium(III) and 1.789(5) Å in 
iridium(III) species, respectively); however the angles between the 
pentamethylcyclopentadienyl (A) and the 8-quinolinolato rings (B,C) 
differ significantly (Table 3, Figure 5b). The difference between the 
structures of these organorhodium and organoiridium complexes 
can be due to dissimilar secondary interactions with neighbouring 
molecules as different molecular arrangements and solvate 
inclusion realized in the two kinds of crystal structures. In the 
crystal lattice of the rhodium(III) complex the molecules are packed  
Table 3 Selected bond distances (Å) and angles (o) of the metal complexes 
[Rh(5-C5Me5)(8-quinolinolato)(Cl)] (1) and [Ir(
5-C5Me5)(8-quinolin-
olato)(Cl)] (VUMQAW22) 
 M = Rh (1) M = Ir (VUMQAW)22 
Bond length (Å) 
M‒Cl1 2.417(2) 2.386(2) 
M‒O1 2.099(4) 2.091(6) 
M‒N1 2.116(5) 2.088(7) 
M‒C1 2.165(5) 2.163(12) 
M‒C2 2.144(5) 2.135(13) 
M-‒C3 2.140(6) 2.155(9) 
M‒C4 2.139(6) 2.177(9) 
M‒C5 2.160(6) 2.164(10) 
M‒Cg(A) a 1.768(3) 1.789(5) 
M‒Cg(BC) a 2.139(6) 2.177(9) 
Bond angles (o) 
O1‒M‒N1 78.4(2) 77.8(3) 
O1‒M‒Cl1 86.5(1) 84.6(2) 
N1‒M‒Cl1 90.7(1) 85.2(2) 
Cg(A)‒M-O1 a 127.85(12) 131.2(2) 
Cg(A)‒M-N1 a 130.73(15) 133.2(2) 
Cg(A)‒M-Cl1 a 126.74(9) 126.8(2) 
Cg(A)‒Cg(BC) b 49.0(3) 60.9(5) 
a Cg is the center of gravity calculated for rings A or BC. b Angles 
between planes calculated for the rings A and BC 
 
 
 
Fig. 6. Packing arrangement showing water channels viewing along the c 
crystallographic axis in crystal [Rh(5-C5Me5)(8-quinolinolato)(Cl)] (1). 
 
in a way that channels are formed (Figure 6). The volume of the 
solvent accessible voids are 157 Å
3
 calculated by program 
PLATON.
42 
Selected secondary interactions are shown in Figure S4, 
and the collection of the main intermolecular interactions is listed 
in Table S2. It is worth mentioning that the isolated [Rh(
5
-
(a) (b)
(a) (b)
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C5Me5)(L)(Cl)] complex was also characterized in this work by 
1
H 
NMR spectroscopy and electrospray ionization mass spectrometry, 
confirming the coordination of the ligand to the metal center. 
 
Complex formation equilibria of [Ru(
6
-p-cymene)(H2O)3]
2+ 
with 
HQ, HQS and PHQ 
The complex formation of [Ru(
6
-p-cymene)(H2O)3]
2+ 
with the 
chosen 8-hydroxyquinoline ligands is a rather slow process 
compared to the case of the Rh(
5
-C5Me5) species due to the 
markedly increased trans effect of the anionic 
pentamethylcyclopentadienyl ligand in comparison to neutral arene 
ligand. E.g. the equilibrium could be reached after more than 
120 min in the [Ru(
6
-p-cymene)(H2O)3]
2+
 ‒ HQS system at pH 3 as 
the time-dependence of the UV-vis spectra indicates (Figure S5), 
which hindered the application of conventional pH-potentiometric 
titrations. To overcome this problem, individual samples were 
prepared by the addition of different amount of strong base under 
Ar, and the actual pH and the UV-vis and/or 
1
H NMR spectra were 
measured after 24 h. Besides the altered complexation kinetics of 
the organorhodium and organoruthenium compounds with the 8-
hydroxyquinolines, the other most conspicuous difference is that 
 
 
 
 
Fig. 7. Time-dependent UV–Vis absorbance spectra of [Ru(6-p-
cymene)(H2O)3]
2+ – HQS (1:2) system at pH 7.4 under aerobic condition (a) 
and under Ar atmosphere (b); red dashed spectrum is calculated as sum of 
those of [Ru(6-p-cymene)(HQS)(H2O)] and 1 eq. HQS. Inset (in a) shows the 
time-dependent changes of absorbance at 406 nm and 530 nm, the symbol 
colors correspond to the spectrum coloring. {cRu = 223 M; cHQS = 444 M; 
pH = 7.4 (20 mM phosphate buffer); T = 25 ˚C}. 
pH values. As a consequence logK [ML] constants were determined 
from the UV-Vis spectral changes in the pH range from 0.7 to 3.0 for 
the HQ and PHQ complexes (Table 2). Although, the spectra 
recorded at pH 0.7 and 3 for the [Ru(
6
-p-cymene)(H2O)3]
2+
 ‒ HQS 
were almost identical due to the negligible decomposition of the 
complex under the strongly acidic conditions. Therefore the stability 
constant could not be obtained based on these UV-Vis spectra. Only 
a lower limit for the logK [ML] stability constant (Table 2) could be 
estimated from the 
1
H NMR spectrum recorded at pH 0.7 at 1:1 
metal-to-ligand ratio based on the integrated peak areas of the 
isopropyl methyl protons of the p-cymene ring belonging to the 
bound and unbound fractions of the organometallic fragment. 
In the [Ru(
6
-p-cymene)(L)(H2O)] complexes in solution the ligand 
coordinates most probably in the same bidentate manner via the 
(N,O
‒
) donors as in the case of the analogous rhodium(III) species 
(vide supra) and as the crystal structures reported for both [Ru(
6
-
p-cymene)(8-quinolinolato)(Cl)]
23
 and [Ru(
6
-p-cymene)(8-
quinolinolato)(H2O)]
+ 24
 complexes also show. Deprotonation of the 
coordinated water molecule in the [Ru(
6
-p-cymene)(L)(H2O)] 
species was characterized by the pKa [ML] values determined by the 
deconvolution of the 
1
H NMR (only in the case of HQS) and UV-Vis 
spectra (Table 2). pH-dependent 
1
H NMR spectra in a 10% 
DMSO/D2O mixture were also reported for the [Ru(
6
-p-
cymene)(L)Cl)] complex of HQ, however no time-dependent 
measurements were performed and no pKa [ML] was provided.
21
 It 
is noteworthy that the logK [ML] values are higher, while pKa [ML] 
constants are lower by ca. 1-1.5 orders of magnitude obtained for 
the Ru(
6
-p-cymene) complexes compared to the those of the 
Rh(
5
-C5Me5) counterparts. Based on these values it can be 
predicted that the deprotonation of the Ru(
6
-p-cymene) complex 
formed with HQS, where pKa [ML] is the lowest among the studied 
complexes, takes place still at a low extent at physiological pH. 
(Formation of ca. 7% [ML(OH)] is estimated in the chloride-free 
medium at 50 M concentration of the mono complex in this 
particular case).  
In the presence of ligand excess novel bands appeared 
unexpectedly in the UV-Vis spectra recorded for the [Ru(
6
-p-
cymene)(H2O)3]
2+
 ‒ HQS (1:2) system at pH 7.4 (Figure 7). As the 
complex formation is slow, it was expected that the final spectrum 
is the sum of those of the [Ru(
6
-p-cymene)(L)(H2O)] mono complex 
and one equivalent unbound ligand (see the red dashed lines in 
Figure 7). In addition, the development of these new bands 
depends on the conditions, namely different spectral changes were 
observed under aerobic conditions or under Ar atmosphere. The 
solution turned to be green with time in the presence of O2 (λmax ~ 
406 nm), on the contrary when Ar was bubbling though the sample 
it became reddish (λmax ~ 530 and 406 nm). It should be noted that 
in the case of the Ar atmosphere the presence of minor O2 was 
possible. The absorbance values at both wavelength maxima 
become much higher with time than it is expected (see inset of 
Figure 7.a). The band at 406 nm most probably appears as a 
consequence of O2, as the absorbance increased significantly when 
O2 gas was purged through the samples kept under Ar previously, 
while the band at 530 nm was decreased (Figure S6). 
Additionally, the 
1
H NMR spectrum recorded at 1:2 metal-to-ligand 
ratio (in air) at pH 7.4 showed intense broadening of the signals. All 
these findings strongly suggest that HQS is able to replace the arene 
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ring at least partly, and this process sensitizes ruthenium(II) to 
oxidation. In order to confirm the formation of ruthenium(III) in the 
[Ru(
6
-p-cymene)(H2O)3]
2+
 ‒ HQS system, EPR spectra were 
recorded at pH 7.4 and at 11.1 as well at ligand excess (Figure S7). 
The EPR spectra undoubtedly show that the oxidation of the 
ruthenium center took place indeed at both pH values. The 
appearance of ruthenium(III) was also seen in the case of HQ 
(Figure S8). Partial loss of the arene ligand was reported for [Ru(
6
-
biphenyl)(L)Cl] complexes where L = 2,2’-bipyridine or 3,3’-hydroxy-
2,2’-bipyridine during the aquation, however the report does not 
indicate the pH-range for the process.
43
 On the other hand, the co-
incubation of the [Ru(
6
-p-cymene)(8-quinolinolato)Cl)] complex 
with cysteine, that has a strong binding affinity towards Ru(
6
-p-
cymene), led to the quick release of the arene moiety and 
degradation of the complex.
21 
 
Comparison of the solution stability of the studied organometallic 
complexes 
In order to compare the solution stability of the Ru(
6
-p-cymene) 
and Rh(
5
-C5Me5) complexes formed with the 8-hydroxyquinoline 
ligands HQ, PHQ and HQS there are several possibilities. However, 
the direct comparison of the determined logK [ML] values (Table 2) 
is not adequate, since the complex formation equilibrium is 
superimposed by other accompanying equilibria, such as 
(de)protonation of the ligands and hydrolysis of the organometallic 
cations. Conditional stability constants (logK’ [ML]) taking into 
consideration the different basicities of the ligands can be 
computed at a fixed pH value or as a function of pH.
44
 Thus 
logK’ [ML] values were calculated at pH 7.4 (Figure 8.a) for the 
complexes of the studied 8-hydroxyquinolines, which give the 
following order: HQS > HQ > PHQ in case of both organometallic 
cations. 
Another option is the calculation of pM values for a particular 
ligand. Basically pM is the negative logarithm of the equilibrium 
concentration of the unbound metal ion, and a higher pM value 
indicates a stronger metal ion binding ability of the ligand under 
given circumstances. The tendency of these organometallic 
fragments to hydrolyze shows remarkable differences, which has to 
be taken into account for a more adequate comparison of the 
complex stabilities. Namely, the hydrolysis of the [Ru(
6
-p-
cymene)(H2O)3]
2+
 cation is stronger and occurs at lower pH values 
compared to [Rh(
5
-C5Me5)(H2O)3]
2+
,
16,36
 thus the extent of 
competition between a given ligand and the hydroxide ion for the 
metal is different as well. Therefore formation of the various 
hydroxido species ([(Rh(
5
-C5Me5))2(μ-OH)3]
+
, [(Rh(
5
-C5Me5))2(μ-
OH)2]
2+
 and [(Ru(
6
-p-cymene)2(μ-OH)3]
+
), which are all unbound 
forms of the metal ions besides the triaqua species, should be 
considered and pM* values (pM* = –log([M] + [M2(OH)3] + 
[M2(OH)2]) were computed at pH 7.4 using the experimentally 
determined stability constants instead of the simple pM (Figure 
8.b). pM* values are shown in the pH range from 2 to 10.5 for 
complexes of HQ in Figure S9.  
The pM*7.4 values show the same trend of the metal binding 
effectiveness of the investigated ligands as the conditional stability 
constants (Figure 8.a), although they are always higher for the 
Rh(
5
-C5Me5) complexes due to the higher affinity of Ru(
6
-p-
cymene) towards the hydroxide ions diminishing the ligand-bound 
fractions. It is worth mentioning that these pM*7.4 values indicate 
the formation of very high stability complexes, even in the case of 
the lowest value ((Ru(
6
-p-cymene) complex of PHQ) 
decomposition of less than 1% is estimated at 50 M concentration. 
The predominant species at pH 7.4 is the [ML] type complex in all 
cases. These findings suggest that the studied organometallic 
complexes are able to retain their bidentate 8-hydroxyquinoline 
ligand in the coordination sphere under physiological condition (at 
pH 7.4, biologically relevant low concentrations) and merely 
substitution of the aqua ligand by chloride (or vice versa) or by 
donor atoms of bioligands such as proteins in the biofluids is 
probable.  
 
Chloride ion affinity and lipophilicity of the studied organometallic 
complexes 
In most of the half-sandwich Ru(
6
-p-cymene) and Rh(
5
-C5Me5) 
complexes of bidentate ligands a chloride ion is coordinated as a 
leaving group in the solid forms. Aquation (Cl
‒
/H2O exchange) 
followed by dissolution in aqueous solution is known to be an 
 
 
Fig. 8. Conditional stability constants (logK’ [ML]) of [Rh(5-C5Me5)(L)(H2O)] (black bars) and [Ru(
6-p-cymene)(L)(H2O)] (grey bars) complexes of HQS, HQ and 
PHQ at pH 7.4. K’ [ML] = K [ML] / αH, where αH = 1 +             . {T= 25 °C; I = 0.20 M (KNO3)} (a). pM* values at pH 7.4, where pM* = – log([M] + 
[M2(OH)3] + [M2(OH)2]) {cM = 50 M; M:L = 1:1; T= 25 °C; I = 0.20 M (KNO3)} (b). 
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important step of mechanism of activation for many anticancer 
drugs such as cisplatin,
45
 and has a key role in the DNA/protein 
interactions. In the case of Ru(
6
-arene) complexes it is also 
assumed that the aqua complex [Ru(
6
-arene)(L)H2O] is responsible 
for the bioactivity, therefore the exchange of the chlorido ligand to 
water should occur with adequate rate and extent.
46
 The hydrolysis 
of the M‒Cl bond was found to be fairly fast for the studied 8-
hydroxyquinoline complexes, the equilibrium could be reached 
within some minutes. The immediate formation of the aqua species 
from the [Ru(
6
-p-cymene)(8-quinolinolato)Cl)] complex was 
reported by Kubanik et al.
21
 in conjunction with our findings. In our 
experimental setup the following equilibrium process was studied 
spectrophotometrically: [M(L)(H2O)] + Cl
–
 ⇌ [M(L)(Cl)] + H2O. The 
displacement of water by chlorido ligand results in characteristic 
spectral changes in the UV-Vis spectra as Fig. 9 shows for the Rh(
5
-
C5Me5) complex of HQS. Namely, λmax is increased with increasing 
absorbance upon the higher and higher chloride ion concentrations 
at pH 7.4. 
Equilibrium constants (see logK′ (H2O/Cl
−
) values in Table 2) and the 
individual spectra of the aquated and chlorinated complexes could 
be estimated by the deconvolution of the measured spectra (see 
inset in Figure 9). The equilibrium constants of the Ru(
6
-p-cymene) 
complexes are more than one order of magnitude lower compared 
to those of the Rh(
5
-C5Me5), reflecting a significantly lower affinity 
of these ruthenium(II) species towards the chloride ion and an 
easier replacement by water or by donor atoms of biomolecules. 
The ratio of the aquated and chlorinated species depends on the 
actual concentration of the chloride ions. The distribution of these 
species was estimated for the HQ complexes based on the 
determined logK′ (H2O/Cl
−
) constants at 100, 24 and 4 mM chloride 
content in accordance with the blood serum, cell plasma and cell 
nucleus,
45
 respectively (Figure 10). It can be concluded that the 
extent of aquation is higher for the Ru(
6
-p-cymene) complexes, 
and it is assumed that 97% and 80% of the organoruthenium and 
the organorhodium complexes respectively are present in solution 
as the more reactive aqua species at 4 mM chloride ion 
concentration. 
The dependence of cytotoxicity on chloride ion affinity has been 
reported for several Ru(
6
-arene) complexes
47
 as well as for a series 
of Rh(
5
-C5Me5) compounds.
41
 However, besides the chloride 
affinity the lipophilicity is another crucial factor determining the 
antiproliferative activity as it influences the solubility and the 
passage through the cell membrane. 
Lipophilicity of the half-sandwich organometallic complexes is not 
only governed by the lipophilic character of the coordinated ligand 
and the arene/arenyl moiety, but the chloride/water exchange has 
also an impact on the lipophilic character as it alters the net charge 
of the complexes. Therefore, distribution coefficients at pH 7.4 
(logD7.4) were determined for the complexes of HQ and PHQ at 
various chloride ion concentrations (Table 4). LogD7.4 values for the 
ligands and the organometallic cations are also shown for 
comparison, but data were not determined for the HQS complexes 
as they were found to be non-cytotoxic (IC50 > 100 M in the cell 
lines studied, see next section) most likely due to their much 
stronger hydrophilic character. A calculated logP value of +0.46 was 
reported for the complex [Ru(
6
-p-cymene)(8-quinolinolato)Cl)],
21 
 
 
Fig. 9. Measured (●) and fitted (dotted line) absorbance values at 384 nm at 
various chloride ion concentrations in the [Rh(5-C5Me5)(H2O)3]
2+ – HQS (1:1) 
system at pH 7.4. Inset shows the individual calculated molar absorbance 
spectra of [Rh(5-C5Me5)(L)(H2O)] (grey spectrum) and [Rh(
5-C5Me5)(L)(Cl)]
‒ 
(black spectrum). {cL = cRh = 160 M; cCl‒ = 0-0.08M; T = 25 ˚C}. 
 
 
Fig. 10. Estimated distribution (%) of the aqua (filled bars) and chlorido 
(empty bars) complexes of HQ formed with Rh(5-C5Me5) (black) and Ru(
6-
p-cymene) (grey) at 100, 24 and 4 mM concentration of chloride ions 
calculated on the basis of the exchange constants (logK’ (H2O/Cl
‒)).  
{cL = cM = 100 M; pH = 7.40; T = 25 ˚C}. 
 
 
but the possible Cl
−
/ H2O exchange was not taken into 
consideration. Based on data in Table 4 it can be concluded that the 
HQ complexes are more lipophilic than the PHQ species similarly to 
the case of the metal-free ligands. The lower logD7.4 value of PHQ is 
a consequence of the protonated piperidinium moiety. On the 
other hand the general trend for the increasing lipophilicity of the 
metal complexes is observed with increasing chloride ion 
concentration as the compounds become more chlorinated, thus 
the net charge turns to be lower (e.g. [M(L)(H2O)]
+
 → [M(L)(Cl)] in 
the case of HQ complexes). In the absence of chloride ions both the 
triaqua and the mono-ligand aqua complexes are more lipophilic in 
the case of the Ru(
6
-p-cymene), however the logD7.4 values are 
higher for the Rh(
5
-C5Me5) complexes of HQ, PHQ when chloride 
ions are present in the solution, thus in the coordination sphere. 
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Consequently, the lipophilicity of these organometallic complexes 
shows a strong dependence on the actual chloride ion 
concentration. 
 
Cytotoxic activity and MDR-selective activity in cancer cell lines 
The cytotoxic effect of ligand HQ and its Ru(
6
-p-cymene) and 
Rh(
5
-C5Me5) complexes measured in various cancer cell lines has 
been already reported. A recent study of Kubanik el al. provides IC50 
values of 1.97–5.96 M for HQ and 11.4–19.3 M for [Ru(
6
-p-
cymene)(8-quinolinolato)Cl)] in human colorectal (HCT116), non-
small cell lung (NCI-H460), and cervical carcinoma (SiHa) cells.
21
 The 
metal complex showed good activity that is clearly associated with 
the cytotoxic activity of the ligand. Similar IC50 values were obtained 
for this ruthenium(II) complex in ovarian (CH1) and colon carcinoma 
(SW480) cell lines.
20
 The [Rh(
5
-C5Me5)(8-quinolinolato)Cl)] 
complex was found to be active in human melanoma and 
glioblastoma cells (IC50 ~0.8–100 M) and showed good activity 
against Gram-positive bacteria as well.
19
 The piperidine derivative 
of HQ (PHQ) is also a cytotoxic compound and has a strong 
preference for targeting MDR cell lines, while HQ does not exert 
MDR-selectivity.
29
  
Here, our aim was to reveal whether the complexation of PHQ with 
the studied orgamometallic cations resulting in the formation of 
very high stability complexes can modify the intrinsic cytotoxic 
effectiveness and the MDR-selectivity of the ligand. 
The cytotoxic activity of PHQ, HQ and HQS was investigated in the 
absence and in the presence of one equivalent [Ru(
6
-p-
cymene)(H2O)3]
2+
 or [Rh(
5
-C5Me5)(H2O)3]
2+
 cations in MES-SA 
(human uterine sarcoma) and in its multidrug-resistant counterpart 
(MES-SA/Dx5) cell lines by means of the colorimetric 3-(4,5-
dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) 
assay, as detailed in the experimental section. The resistance of 
MES-SA/Dx5 cells is primarily mediated by the overexpression of P-
gp, a member of the ABC transporter family, which pumps out 
xenobiotics from the cells. P-gp expression is significantly increased 
in multidrug-resistant tumor cells resulting in decreased 
intracellular drug accumulation. In order to show the effect of the 
active pump, experiments were also performed in the presence of 
the P-gp-inhibitor Tariquidar (TQ), which binds with high affinity to 
the P-gp transporter. The clinical drug and P-gp substrate 
doxorubicin was used as a positive control. As a further control, the 
cytotoxicity of the organometallic cations was measured as well. 
 
 
Table 4 n-Octanol/water distribution coefficients at pH 7.4 (logD7.4) for the [Rh(
5-C5Me5)(L)(Z)] and [Ru(
6-p-cymene)(L)(Z)] (Z = H2O/Cl
‒; charges are omitted 
for clarity) complexes formed with HQ and PHQ as well as the corresponding free ligands and organometallic precursors for comparison at various chloride ion 
concentrations {T = 25 C, pH = 7.4 (20 mM phosphate buffer}.a 
logD7.4 Rh(
5-C5Me5)  Ru(
6-p-cymene)  ligand alone 
cCl‒ =  0.0 M 0.1 M 0.5 M  0.0 M 0.1 M 0.5 M  0.1 M 
HQ ‒0.63(2) +0.75(3) +0.80(1)  +0.10(1) +0.54(1) +0.78(8)  +1.81(2)b 
PHQ ‒1.22(4) ‒0.55(1) ‒0.31(1)  ‒1.05(1) ‒0.78(1) ‒0.59(1)  +0.93(4) 
no ligand ‒2.00c ‒0.61c  ‒0.46c  ‒1.71(2) ‒0.46(2) +0.33(8)  ‒ 
a Uncertainties (SD) of the last digits are shown in parentheses. b LogD7.4 = +1.78.
48 c Data taken from ref. 18.  
 
Table 5 In vitro cytotoxicity (IC50 values in μM) of the [Rh(
5-C5Me5)(L)(Z)] and [Ru(
6-p-cymene)(L)(Z)] (Z = H2O/Cl
‒; charges are omitted for clarity) complexes 
formed with HQ, HQS and PHQ as well as the corresponding free ligands, organometallic precursors and doxorubicin for comparison in two human cancer cell 
lines in the presence or absence of TQ (72 h exposure). 
 
IC50 / M MES-SA MES-SA/Dx5 
MES-SA 
+ 1 M TQ 
MES-SA/Dx5 
+ 1 M TQ 
 Doxorubicin 0.087 ±0.022 3.1 ±1.1 0.064 ±0.013 0.036 ±0.008 
 [Ru(6-p-cymene)(Z)3] > 100 > 100 > 100 > 100 
 [Rh(5-C5Me5)(Z)3] > 100 > 100 > 100 > 100 
H
Q
 ligand 3.3 ± 1.1 
1.08 ± 0.26 3.7 ± 1.3 1.28 ± 0.07 
[Ru(6-p-cymene)(L)(Z)] 13.1 ± 4.1 3.57 ± 0.61 11.87 ± 0.27 4.6 ± 1.1 
[Rh(5-C5Me5)(L)(Z)] 3.57 ± 0.93 2.03 ± 0.27 4.24 ± 0.24 2.00 ± 0.25 
P
H
Q
 ligand 3.63 ± 0.58 0.62 ± 0.03 3.46 ± 0.02 3.75 ± 0.51 
[Ru(6-p-cymene)(L)(Z)] 5.25 ± 0.88 19.8 ± 5.4 5.54 ± 0.70 66 ± 33 
[Rh(5-C5Me5)(L)(Z)] 4.63 ± 0.35 0.90 ± 0.12 4.75 ± 0.07 4.41 ± 0.41 
H
Q
S 
ligand > 100 > 100 > 100 > 100 
[Ru(6-p-cymene)(L)(Z)] > 100 > 100 > 100 > 100 
[Rh(5-C5Me5)(L)(Z)] > 100 > 100 > 100 > 100 
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Fig. 11. pIC50 (= ‒log (IC50 expressed in μM)) values measured in MES-SA/Dx5 cells of the ligand HQ (a) and PHQ (b) with their Rh(
5-C5Me5) and Ru(
6-p-
cymene) complexes plotted against to those obtained in MES-SA cells in the absence (filled symbols) or in the presence (empty symbols) of TQ. Symbols: ligand 
alone (♦), Rh(5-C5Me5) complexes (●), Ru(
6-p-cymene) complexes (▲). Selectivity ratio (IC50 (MES-SA) / IC50 (MES-SA/Dx5)) for ligands (Lig: HQ, PHQ) and their 
Ru(6-p-cymene) (Ru) and Rh(5-C5Me5) (Rh) complexes in the absence (left darker bars) or in the presence (right lighter bars) of TQ (c).  
 
The IC50 values are collected in Table 5. Notably, the toxicity of the 
organometallic cations and the HQS containing samples is 
negligible. The cytotoxicity of the ligands HQ and PHQ in MES-SA 
cell lines is very similar, and both are more active in MES-SA/Dx5 
cells, however the selectivity ratio, i.e. IC50 (MES-SA) / IC50 (MES-
SA/Dx5), is much higher for PHQ that is considered as a MDR 
selective compound.
29
 For a better comparison of the biological 
data the pIC50 values obtained in the MES-SA/Dx5 cells are plotted 
against those of the MES-SA cells (Figure 11a,b) and the selectivity 
ratio is also shown for the ligands and the metal complexes (Figure 
11c). 
The selectivity ratio is an indicator of the increased sensitivity of the 
MDR MES-SA/Dx5 cell line as compared to the parental MES-SA cell 
line. A selectivity ratio > 2 indicates that MES-SA/Dx5 cells are 
paradoxically more sensitive, rather than more resistant, to a given 
compound. It is important to note that collateral sensitivity may be 
limited to a particular cell line.
30,49
 To establish the requirement of 
functional P-gp, we repeated the cytotoxicity experiments in the 
presence of the P-gp-inhibitor TQ. As expected, TQ has no impact 
on the IC50 values of all the studied compounds in the case of the P-
gp negative parental MES-SA cells. In contrast, by inhibition of the 
transporter, MES-SA/Dx5 cells become more sensitive to the P-gp 
substrate doxorubicin. The cytotoxicity of the ligand HQ and its 
complexes is independent from the presence of TQ in the MES-
SA/Dx5 cell lines. On the contrary, higher IC50 values were observed 
for ligand PHQ and its Rh(
5
-C5Me5) complex in MES-SA/Dx5 cells 
when TQ was added to the samples, proving that the cytotoxicity is 
indeed potentiated by P-gp. The IC50 values obtained for Ru(
6
-p-
cymene) and Rh(
5
-C5Me5) complexes of HQ and PHQ are similar to 
those of the free ligands, although the values are somewhat higher 
in the case of the Ru(
6
-p-cymene) complexes in MES-SA and MES-
SA/Dx5 cells. As a consequence, the selectivity ratio remained low 
and unaffected by the complexation in the case of the non-MDR 
selective compound HQ (Figure 11c). The selectivity ratio calculated 
for PHQ and its Rh(
5
-C5Me5) complex is fairly high, while the 
complex formation with Ru(
6
-p-cymene) seems to abolish MDR 
selective activity. The altered behavior of the Ru(
6
-p-cymene) and 
Rh(
5
-C5Me5) complexes of PHQ most likely cannot be explained 
simply on the basis of the solution speciation data and their 
lipophilic character, which shows dependence on the chloride ion 
concentration. Both complexes possess undoubtedly high stability, 
whereas their decomposition is assumed to be negligible in solution 
under physiological conditions. On the other hand, the Ru(
6
-p-
cymene) complex is kinetically more inert, it has somewhat lower 
0
2
4
6
L
ig
a
n
d
 H
Q
R
u
-c
o
m
p
le
x
R
h
-c
o
m
p
le
x
S
e
le
c
ti
v
it
y
 r
a
ti
o (c)
0
2
4
6
L
ig
a
n
d
 P
H
Q
R
u
-c
o
m
p
le
x
R
h
-c
o
m
p
le
x
Lig Ru Rh Lig Ru Rh
HQ                           PHQ    
HQ PHQ
4.0
4.5
5.0
5.5
6.0
6.5
4.0 4.5 5.0 5.5 6.0 6.5
p
IC
5
0
(M
E
S
-S
A
/D
x
5
)
pIC50 (MES-SA)
(a)
4.0
4.5
5.0
5.5
6.0
6.5
4.0 4.5 5.0 5.5 6.0 6.5
p
IC
5
0
(M
E
S
-S
A
/D
x
5
)
pIC50 (MES-SA)
(b)
Journal Name  ARTICLE 
This journal is © The Royal Society of Chemistry 20xx J. Name., 2017, 00, 1-3 | 11  
Please do not adjust margins 
Please do not adjust margins 
chloride-affinity, thus more double positively charged mono-aqua 
[Ru(
6
-p-cymene)(L)(H2O)]
2+
 species are present in the solution, and 
the complex has slightly more hydrophilic character in the medium 
containing chloride ions at concentration ≤ 100 mM. These features 
can affect the biological activity; however other factors such as the 
3D structure, or the interaction with bioligands might also be 
relevant. 
Experimental 
Chemicals 
All solvents were of analytical grade and used without further 
purification. HQ, HQS, [Rh(
5
-C5Me5(-Cl)Cl]2, [Ru(
6
-p-cymene)(-
Cl)Cl]2, KCl, KNO3, AgNO3, HCl, HNO3, KOH, 4,4-dimethyl-4-
silapentane-1-sulfonic acid (DSS), dimethyl sulfoxide (DMSO), 
NaH2PO4 and Na2HPO4 were purchased from Sigma-Aldrich in puriss 
quality. Ligand PHQ (NSC57969) was acquired from the drug 
repository of Developmental Therapeutics Program of National 
Cancer Institute. Doubly distilled Milli-Q water was used for sample 
preparation. The exact concentration of the ligand stock solutions 
together with the proton dissociation constants were determined 
by pH-potentiometric titrations with the use of the computer 
program HYPERQUAD.
50
 The aqueous [Rh(
5
-C5Me5)(H2O)3](NO3)2 
and [Ru(
6
-p-cymene)(H2O)3](NO3)2 stock solutions were obtained 
by dissolving exact amounts of [Rh(
5
-C5Me5(-Cl)Cl]2 or [Ru(
6
-p-
cymene)(-Cl)Cl]2 respectively in water followed by the removal of 
chloride ions by addition of equivalent amounts of AgNO3. The 
exact concentrations of [Rh(
5
-C5Me5)(H2O)3]
2+
 and [Ru(
6
-p-
cymene)(H2O)3]
2+
 were determined by pH-potentiometric titrations 
employing stability constants for [(Rh(
5
-C5Me5))2(-OH)i]
(4-i)+
 (i = 2 
or 3)
16
 and [(Ru(
6
-p-cymene))2(-OH)3]
+ 37
 complexes, respectively. 
pH-Potentiometric measurements 
pH-potentiometric measurements determining proton dissociation 
constants of ligands HQ and HQS and overall stability constants for 
tested Rh(
5
-C5Me5) ‒ HQS complexes were carried out at 25.0 ± 
0.1 °C in water and at a constant ionic strength of 0.20 M KNO3. The 
titrations were performed in a carbonate-free KOH solution (0.20 
M). The exact concentrations of HNO3 and KOH solutions were 
determined by pH-potentiometric titrations. An Orion 710A pH-
meter equipped with a Metrohm “double junction” combined 
electrode (type 6.0255.100) and a Metrohm 665 Dosimat burette 
were used for the pH-potentiometric measurements. The electrode 
system was calibrated to the pH = −log[H
+
] scale by means of blank 
titrations (strong acid vs. strong base: HNO3 vs. KOH), as suggested 
by Irving et al.
51
 The average water ionization constant, pKw, was 
determined as 13.76 ± 0.01 at 25.0 °C, I = 0.20 M (KNO3), which is in 
accordance to literature.
52
 The reproducibility of the titration points 
included in the calculations was within 0.005 pH units. The pH-
potentiometric titrations were performed in the pH range between 
2.0 and 11.5. The initial volume of the samples was 10.0 mL. The 
ligand concentration was 1.0 mM and was investigated at metal 
ion-to-ligand ratios of 1:1, 1:1.5, and 1:2. The accepted fitting 
between the measured and calculated titration data points 
regarding the volume of the titrant was < 10 L. Samples were 
degassed by bubbling purified argon through them for about 10 
minutes prior to the measurements and the inert gas was also 
passed over the solutions during the titrations. 
The computer program PSEQUAD
53
 was utilized to establish the 
stoichiometry of the complexes and to calculate the overall stability 
constants. (MpLqHr) is defined for the general equilibrium: pM + qL 
+ rH ⇌ MpLqHr as (MpLqHr) = [MpLqHr]/[M]
p
[L]
q
[H]
r
; where M 
denotes the metal moiety [Rh(
5
-C5Me5)(H2O)3]
2+
 or [Ru(
6
-p-
cymene)(H2O)3]
2+
 and L the completely deprotonated ligand.  
values for the various hydroxido complexes [(Rh(
5
-C5Me5))2(-
OH)i]
(4-i)+
 (i = 2 or i = 3) or [(Ru(
6
-p-cymene))2(-OH)3]
+ 
were 
calculated based on the pH-potentiometric titration data in the 
absence of chloride ions and were found to be in good agreement 
with our previously published data.
16,37
 
 
UV–Vis spectrophotometric, 
1
H NMR EPR and ESI-MS 
measurements  
A Hewlett Packard 8452A diode array spectrophotometer was used 
to record the UV-Vis spectra in the interval 200–800 nm. The path 
length was 1 or 0.2 cm. Equilibrium constants (proton dissociation, 
stability constants and H2O/Cl
−
 exchange constants) and the 
individual spectra of the species were calculated with the computer 
program PSEQUAD.
53
 The spectrophotometric titrations were 
performed in pure water on samples containing the ligands with or 
without the organometallic cations and the concentration of the 
ligands was 150-200 M or 1 mM (HQ and HQS) and 75 M (PHQ). 
The organometallic cations were also titrated (200 M). The metal-
to-ligand ratios were 1:1 and 1:2 in the pH range from 2 to 11.5 at 
25.0±0.1 °C at an ionic strength of 0.20 M (KNO3). Measurements 
for 1:1 metal-to-ligand systems were also carried out by preparing 
individual samples in which KNO3 was partially or completely 
replaced by HNO3 and pH values, varying in the range ca.0.7–2.0, 
were calculated from the strong acid content. In the case of the 
Ru(
6
-p-cymene) complexes the absorbance data were always 
recorded after 24 h of incubation. UV-Vis spectra were used to 
investigate the H2O/Cl
−
 exchange processes of complexes [Rh(
5
-
C5Me5)(L)(H2O)] and [Ru(
6
-p-cymene)(L)(H2O)]
 
at 120-160 M (HQ, 
HQS) or 50 M (PHQ) concentration and at pH 7.40 (using 20 mM 
phosphate buffer) as a function of chloride concentrations (0–
330 mM).  
1
H NMR studies were carried out on a Bruker Ultrashield 500 Plus 
instrument. All 
1
H NMR spectra were recorded with the 
WATERGATE water suppression pulse scheme using DSS internal 
standard. Ligand HQS was dissolved in a 10% (v/v) D2O/H2O mixture 
to yield a concentration of 1 mM and were titrated at 25 °C, at I = 
0.20 M (KNO3) in absence or presence of [Rh(
5
-C5Me5)(H2O)3]
2+
 at 
1:1 metal-to-ligand ratio in the pH range between 2.0 and 11.5. 
1
H 
NMR spectra were recorded on samples containing [Ru(
6
-p-
cymene)(H2O)3]
2+
 and HQS at 1:2 ratio after 24 h of incubation. 
Stability constants for the complexes were calculated by the 
computer program PSEQUAD.
53
 
All continuous-wave (CW) EPR spectra were recorded with a 
BRUKER EleXsys E500 spectrometer (microwave frequency 9.81 
GHz, microwave power 10 MW, modulation amplitude 5 G, 
modulation frequency 100 kHz). EPR spectra were recorded at 10.0 
mM of [Ru(
6
-p-cymene)(H2O)3]
2+
 and the metal-to-HQS ratios were 
1:1 and 1:2 at pH 7.4 and 11.1. 
Electrospray ionization mass spectrometric (ESI-MS) measurements 
were performed using a Micromass Q-TOF Premier (Waters MS 
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Technologies) mass spectrometer equipped with electrospray ion 
source. 
 
Determination of the distribution coefficients  
Distribution coefficients (D7.4) values of the [Ru(
6
-p-cymene)(L)(Z)] 
and [Rh(
5
-C5Me5)(L)(Z)] complexes (where L = deprotonated HQ or 
PHQ; Z = H2O/Cl
–
, charges are omitted for simplicity) and the ligands 
as well as the organoruthenium Ru(
6
-p-cymene) fragment were 
determined by the traditional shake-flask method in n-
octanol/buffered aqueous solution at pH 7.40 (20 mM phosphate 
buffer) at various KCl concentrations (cKCl = 0.0, 0.10, 0.50 M) at 
25.0 ± 0.2 °C as described previously.
54
 Data for the organorhodium 
Rh(
5
-C5Me5) fragment were already published under similar 
conditions.
18
 Two parallel experiments were performed for each 
sample. The complexes or ligands were dissolved in n-octanol pre-
saturated aqueous solution of the buffer at 200 M (HQ and HQS 
complexes) or 75 M (PHQ complexes) concentrations. The 
aqueous solutions and n-octanol (1:1 ratio) were gently mixed with 
360° vertical rotation (~20 rpm) for 3 h to avoid emulsion 
formation, and the mixtures were centrifuged at 5000 rpm for 3 
min by a temperature controlled centrifuge (Sanyo) at 25 °C. After 
separation, UV−Vis spectra of the compounds in the aqueous phase 
were compared to those of the original aqueous solutions and D7.4 
values of the complexes or ligands were calculated as follows: 
[Absorbance (original solution) / Absorbance (aqueous phase after 
separation) – 1]. Absorbances were recorded in the region of λmax 
(250–600 nm).  
 
Synthesis of complex [chlorido(8-hydroxyquinolinato-κN
1
,κO
8
)(η
5
-
1,2,3,4,5-pentamethylcyclopentadienyl)rhodium(III)]) (1) and 
crystallographic structure determination 
Single crystals suitable for X-ray diffraction experiment of 
compound [Rh(
5
-C5Me5)(8-quinolinolato)Cl] (1) were grown from 
water/ethanol solution mixture (2.0 mL) containing HQ ligand (2.9 
mg, 0.02 mmol) and rhodium dimer [Rh(
5
-C5Me5)(-Cl)Cl]2 (6.2 mg, 
0.01 mmol) at neutral pH (adjusted by NaOH solution). The mixture 
was kept in dark at room temperature and after 4 h dark orange 
crystals were formed. 
A single crystal was mounted on a loop and transferred to the 
goniometer. X-ray diffraction data were collected at –170 °C on a 
Rigaku RAXIS-RAPID II diffractometer using Mo-Kα radiation. A 
multi-scan absorption correction was carried out using the program 
CrystalClear.
55
 Sir2014
56
 and SHELXL
57
 under WinGX
58
 software 
were used for structure solution and refinement, respectively. The 
structures were solved by direct methods. The models were refined 
by full-matrix least squares on F
2
. Refinement of non-hydrogen 
atoms was carried out with anisotropic temperature factors. 
Hydrogen atom positions were located in difference electron 
density maps (for water hydrogens) or placed into geometric 
positions. They were included in structure factor calculations but 
they were not refined. The isotropic displacement parameters of 
the hydrogen atoms were approximated from the U(eq) value of 
the atom they were bonded to. The summary of data collection and 
refinement parameters for complex [Rh(
5
-C5Me5)(8-
quinolinolato)Cl]×3H2O are collected in Table S1. Selected bond 
lengths and angles of compounds were calculated by PLATON 
software.
42
 The graphical representation and the edition of CIF files 
were done by the Mercury
59
 and PublCif
60
 software. The 
crystallographic data files for the complexes have been deposited 
with the Cambridge Crystallographic Database as CCDC 1530884.  
The orange crystals were filtered and analyzed by 
1
H NMR (500.13 
MHz, CD3OD): δ (ppm) 8.82 (m, 1H, CH2); 8.28 (d, 
3
J (H,H) = 8 Hz,1H, 
CH4); 7.56 (m 1H, CH6); 7.36 (t, 
3
J (H,H) = 8 Hz, 1H, CH3); 6.97 (d, 
3
J 
(H,H) = 8 Hz, 1H, CH5); 6,94 (d, 
3
J (H,H) = 8 Hz, 1H, CH7); 1.72 (s, 
15H, CH3,C5Me5) and by ESI-MS: m/z = 382 [complex – Cl
–
]
+
. NMr 
and ESI-MS data obtained are similar to those published by 
Sliwinska et al.
19
 and Thai et al.
22
  
 
Cell lines, culture conditions and cytotoxicity tests in cancer cell 
lines 
Cell lines and culture conditions 
The human uterine sarcoma cell lines MES-SA and the doxorubicin 
selected MES-SA-MES-SA/Dx5 were obtained from ATCC (American 
Type Culture Collection) (MES-SA: No. CRL-1976™, MES-SA-MES-
SA/Dx5: No. CRL-1977™). The phenotype of the resistant cells was 
verified using cytotoxicity assays (not shown). Cells were cultivated 
in Dulbecco's Modified Eagle Medium (DMEM, Sigma-Aldrich) and 
supplemented with 10% fetal bovine serum, 5 mmol/L glutamine, 
and 50 units/mL penicillin and streptomycin (Life Technologies). All 
cell lines were cultivated at 37 °C under a humidified atmosphere 
containing 95% air and 5% CO2. 
 
Cell viability assay 
Cytotoxic effects were determined by means of the colorimetric 
microculture MTT assay.
61
 For this purpose, cells were harvested 
from culture flasks by trypsinization, seeded in 100 μL/well aliquots 
into 96-well microculture plates (Sarstedt, Newton, USA) at 5.000 
cells per well and allowed to settle and resume exponential growth 
in drug-free complete culture medium for 12 h to 24 h. Ligands HQ, 
PHQ and HQS were dissolved in 80% (v/v) ethanol/water mixture 
first, diluted in complete culture medium and added to the plates 
where the final ethanol content did not exceed 0.5%. Whereas the 
Rh(
5
-C5Me5) and Ru(
6
-p-cymene) complexes of the ligands were 
prepared in 80% (v/v) ethanol/water mixture in situ by mixing the 
ligand with one equimolar concentration of the organometallic 
cations using their stock solutions containing known amount of 
[Rh(
5
-C5Me5)(H2O)3]
2+
 and [Ru(
6
-p-cymene)(H2O)3]
2+
. Following 
addition of the serial dilutions of ligands and complexes and an 
incubation period of 72 h, the supernatant was removed and fresh 
medium supplemented with the MTT reagent (0.83 mg/mL) was 
added. Incubation with MTT at 37 °C was terminated after 1 h by 
removing the supernatants and lysing the cells with 100 µL DMSO 
per well. Viability of the cells was measured spectrophotometrically 
by absorbance at 540 nm using an EnSpire microplate reader. Data 
were background corrected by subtraction of the signal obtained 
from unstained cell lysates and normalized to untreated cells. 
Curves were fitted by Prism software
62
 using the sigmoidal dose-
response model (comparing variable and fixed slopes). Curve fit 
statistics were used to determine the concentration of test 
compound that resulted in 50% toxicity (IC50). Evaluation is based 
on means from three independent experiments, each comprising 
three replicates per concentration level. Co-incubation experiments 
were also performed in the presence of the P-gp inhibitor TQ (kind 
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gift of Dr. S. Bates, NCI NIH). Doxorubicin (Sigma-Aldrich) was used 
as a positive control. 
Conclusions 
The rational design and optimization of the bioactivity of 
metallodrugs require detailed information about the solution 
behavior, stability and speciation characteristics, especially under 
physiological conditions. Solution equilibrium studies provide 
information about the chemical species present in aqueous solution 
and are of utmost importance for the understanding of the 
mechanism of action of biologically active compounds. The main 
objective of this work was to characterize and compare the solution 
speciation of Ru(
6
-p-cymene) and Rh(
5
-C5Me5) complexes formed 
with various bidentate 8-hydroxyquinoline compounds (HQ, PHQ 
and HQS). Stoichiometry and stability of these organometallic 
complexes were determined in aqueous solution via a combined 
approach using 
1
H NMR spectroscopy, UV-visible spectro-
photometry and pH-potentiometry. X-ray diffraction study of 
[Rh(
5
-C5Me5)(8-quinolinolato)(Cl)] showed pseudo-octahedral 
“piano-stool” geometry, and the deprotonated ligand coordinates 
in a bidentate mode via (N,O
–
) donor atoms. Based on the 
comparative equilibrium studies we concluded that mono-ligand 
complexes with a general formula of [M(L)(H2O)] are formed with 
significantly high solution stability, and their decomposition cannot 
occur even at low micromolar concentrations at physiological pH. 
The trend for the stability of the studied organometallic complexes 
is the following: HQS > HQ > PHQ. The relative affinities of the 8-
hydroxyquinolines towards the organometallic cations are 
somewhat higher with Rh(
5
-C5Me5) at pH 7.4. However, 1-1.5 
orders of magnitude lower pKa values were obtained for the [Ru(
6
-
p-cymene)(L)(H2O)] complexes, mixed hydroxido species [M(L)(OH)] 
are formed only in the basic pH range in all cases due to the 
relatively high pKa values (8.5–10.3). Notably, the complex 
formation rate with [Ru(
6
-p-cymene)(H2O)3]
2+
 is much lower 
compared to the organorhodium triaqua cation. Additionally, 
H2O/Cl
−
 co-ligand exchange constants show the stronger affinity of 
the Rh(
5
-C5Me5) complexes towards chloride ions. As a 
consequence of the aquation of the chlorinated compounds 
([M(L)(Cl)]) the lipophilic character of the studied orgamometallic 
complexes is decreasing with decreasing chloride ion 
concentrations. A somewhat stronger hydrophilic character of the 
Ru(
6
-p-cymene) complexes was found at chloride ion 
concentrations which are biologically relevant. 
In vitro cytotoxicity of the unsubstituted HQ, PHQ (which is 
preferentially toxic to multidrug resistant cell lines) and HQS was 
measured in the absence and in the presence of the [Ru(
6
-p-
cymene)(H2O)3]
2+
 and [Rh(
5
-C5Me5)(H2O)3]
2+
 cations. A cell line 
pair, namely MES-SA (human uterine sarcoma) and its P-gp-
expressing multidrug resistant counterpart (MES-SA/Dx5), was 
used. IC50 values in the low M range were observed except for the 
HQS containing samples. The effect of Tariquidar, a high-affinity P-
gp inhibitor, on the selectivity ratio was also investigated. Ligand 
HQ and its organometallic complexes exhibit a similar cytotoxicity in 
both cell lines and the selectivity ratio is low and unaffected by the 
complexation. At the same time PHQ and its Rh(
5
-C5Me5) complex 
have an increased MDR-selective ratio, however the selectivity is 
abrogated in the case of the Ru(
6
-p-cymene) complex, which might 
be a consequence of its more inert feature and slightly more 
hydrophilic character. 
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